We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cell Phone Intervention to Support Antiretroviral Therapy (ART) Adherence in Kenya

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00830622
First Posted: January 28, 2009
Last Update Posted: June 22, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
University of Nairobi
Information provided by:
University of Manitoba
  Purpose
A clinical study to evaluate the use of cell phones to support drug adherence and follow-up of patients taking antiretroviral therapy (ART) for treatment of HIV. The intervention involves health-care providers sending regular short-message-service (SMS) text messages to patients and following up their responses. The hypothesis is that the cell phone intervention will improve ART adherence and health outcomes compared with the current standard of care.

Condition Intervention
HIV AIDS HIV Infections Other: Cell Phone Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Targeted Cell Phone Intervention to Improve Patient Access to Care and Drug Adherence in Patients Taking Antiretroviral (ARV) Medications in Kenya

Resource links provided by NLM:


Further study details as provided by University of Manitoba:

Primary Outcome Measures:
  • Adherence to ART and HIV RNA suppression [ Time Frame: 6,12 months ]
    Although many patients are seen every 3 months, study visits with questionnaires and viral load are completed at 0, 6, and 12 month scheduled follow-up visits.


Secondary Outcome Measures:
  • Retention [ Time Frame: 6, 12 months ]
  • Quality of Life (SF-12) [ Time Frame: 3, 6, 9, 12 months ]
  • Health (CD4, weight, progression to AIDS, all cause mortality) [ Time Frame: 6, 12 months ]

Enrollment: 536
Study Start Date: May 2007
Study Completion Date: March 2010
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Cell Phone Intervention: participant receives weekly SMS text message from the health care worker.
Other: Cell Phone Intervention
Participant receives weekly SMS text messages from the health care provider.
No Intervention: 2
SOC: Participant receives standard of care support but not weekly SMS text messages from the health care worker.

Detailed Description:
This RCT study focuses on enrolling and following patients initiating ART. Note, a second parallel prospective cohort study enrolls and follows ART experienced patients who have already been taking ART for at least one year before and after the same intervention.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • HIV infected and starting antiretroviral therapy
  • Adequate (daily) access to a cell phone
  • Intending to attend the enrollment clinic for 2 years
  • Consent to participate

Exclusion Criteria:

  • Not meeting inclusion criteria
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00830622


Locations
Kenya
University of Nairobi Clinics
Nairobi, Kenya
Sponsors and Collaborators
University of Manitoba
University of Nairobi
Investigators
Principal Investigator: Richard T Lester, MD, FRCPC University of Manitoba
Study Chair: Joshua Kimani, MBChB University of Manitoba / University of Nairobi
Study Director: Francis A Plummer, MD, FRCPC University of Manitoba
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Richard T. Lester, MD, FRCPC / Principal Investigator, Dept. of Medical Microbiology and Infectious Diseases, University of Manitoba
ClinicalTrials.gov Identifier: NCT00830622     History of Changes
Other Study ID Numbers: H2007:037
CDC PEPFAR PHE KE.07.0045
First Submitted: January 26, 2009
First Posted: January 28, 2009
Last Update Posted: June 22, 2010
Last Verified: January 2009

Keywords provided by University of Manitoba:
HIV/AIDS
Adherence
Antiretroviral Therapy, ART, ARV
Mobile phone, cell phone, telephone
Text message, SMS
Telemedicine
Africa
Resource-limited setting
Counseling, support
treatment experienced

Additional relevant MeSH terms:
HIV Infections
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases